For instance, experimental and clinical data suggest that PLIN2 is involved in the pathophysiology of insulin resistance and type 2 diabetes mellitus [12,13,14], dyslipidemia [5,7,15,16] and fatty liver disease [7,14,17,18,19,20,21,22]. This evidence concerns the gene PLIN2 and Insulin resistance.